Compliance Certificate - Regulation 7(3) Of The SEBI (LODR) Regulations, 2015
In compliance with Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Certificate from the Company and the Registrar and Share Transfer Agent for the half year ended September 30, 2017. Quarterly Statement Of Investor Complaints - Regulation 13 Of The SEBI (LODR) Regulations, 2015
In compliance with Regulation 13 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith a statement for the quarter ended September 30, 2017,giving number of investor complaints pending at the beginning of the quarter, those received during the quarter, disposed of during the quarter and those remaining unresolved if any, at the end of the quarter. Request you to take the same on record. Shareholding for the Period Ended September 30, 2017
Pfizer Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click here Leading healthcare organizations join Walgreens to combat prescription drug abuse by expanding safe medication disposal programme
Leading healthcare organizations AmerisourceBergen, Blue Cross Blue Shield Association, Pfizer and Prime Therapeutics are joining Walgreens to combat the national opioid abuse crisis by expanding the availability of Pfizer, Astellas prostate cancer drug clears late-stage trial
Xtandi was more successful than an anti-hormone therapy alone in improving overall survival in men with non-metastatic castration-resistant prostate cancer. Lupin gets USFDA approval for generic vibra-tabs tablet
The company's product is a generic version of Pfizer Inc's Vibra tablets in the same strength, it added Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the Listing Regulations, please find attached details of the meeting scheduled with an Analyst/Institutional Investor: Please note that the attached schedule is subject to change on account of exigencies on the part of the Analyst/Institutional Investor or the Company. The attached schedule shall also be displayed on the website of the Company - www.pfizerindia.com in compliance with the Regulation 46 of the Listing Regulations.... Scrutinizer's Report
Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed herewith the results of remote e-voting and poll of the 66th Annual General Meeting of the Company held on August 30, 2017 along with Scrutinizer's Report. We hereby inform you that the members at the Annual General Meeting held on August 30, 2017, have appointed Messrs. Walker Chandiok & Co LLP, Chartered Accountants... Proceedings Of The 66Th Annual General Meeting Pfizer Limited
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed proceedings of the 66th Annual General Meeting of the Company held on August 30, 2017. We request you to kindly take the same on record. Analyst / Investor Meet Intimation
Pursuant to Regulation 30 of the Listing Regulations, attached herewith are the details of the meeting scheduled with an Analyst/Institutional Investor. Please note that the attached schedule is subject to change on account of exigencies on the part of the Analyst/Institutional Investor or the Company. This schedule shall also be displayed on the website of the Company - www.pfizerindia.com in compliance with the Regulation 46 of the Listing Regulations....